Andrew L. Pecora, Director at TETRALOGIC PHARMACEUTICALS CORP (TLOG), bought 50,000 shares at $2.54 ($134K) on 2015-07-10, disclosed to the SEC on 2015-07-14.
Open-market purchase of $134k TLOG by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.44 | 10,000 | $24K | 18.2% |
| 2 | $2.54 | 1,300 | $3K | 2.5% |
| 3 | $2.57 | 92 | $236 | 0.2% |
| 4 | $2.65 | 1,092 | $3K | 2.2% |
| 5 | $2.66 | 908 | $2K | 1.8% |
| 6 | $2.69 | 2,100 |
| $6K |
| 4.2% |
| 7 | $2.74 | 6,900 | $19K | 14.1% |
| 8 | $2.74 | 10,000 | $27K | 20.4% |
| 9 | $2.75 | 7,608 | $21K | 15.6% |
| 10 | $2.75 | 800 | $2K | 1.6% |
| 11 | $2.79 | 9,200 | $26K | 19.2% |
| Total | $2.68 avg | 50,000 | $134K | 100% |
| Filing → |
| TLOG | BUY | 2014-11-19 | $91K | — | Filing → |
| TLOG | BUY | 2013-12-19 | $186K | — | Filing → |
| CGIX | SELL | 2013-11-20 | $713K | — | Filing → |